The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition

Shira Kahlon; Dorin Shreibman; Tamar Unger; Dina Ben-Yehuda; Shlomo Elias

doi:10.1038/s41408-018-0082-7

The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition

Shira Kahlon, Dorin Shreibman, Tamar Unger, Dina Ben-Yehuda, Shlomo Elias^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Article number	48
Journal	Blood Cancer Journal
Volume	8
Issue number	5
DOIs	https://doi.org/10.1038/s41408-018-0082-7
State	Published - 1 May 2018
Externally published	Yes

Bibliographical note

Funding Information:
The study was supported by the Israel Science Foundation (grant 502/15), the Kass Medical Research Award, and the Israeli Society of Hematology and Transfusion Medicine (to S.E.). We thank Dr. Svetelana Krichevsky and Ms. Orly Yehuda Weinstein from Hadassah Medical Center for their help in collecting the human patient samples.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41408-018-0082-7

Cite this

@article{47e7f37c5f144ea4af3aaadb57168476,

title = "The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition",

author = "Shira Kahlon and Dorin Shreibman and Tamar Unger and Dina Ben-Yehuda and Shlomo Elias",

note = "Funding Information: The study was supported by the Israel Science Foundation (grant 502/15), the Kass Medical Research Award, and the Israeli Society of Hematology and Transfusion Medicine (to S.E.). We thank Dr. Svetelana Krichevsky and Ms. Orly Yehuda Weinstein from Hadassah Medical Center for their help in collecting the human patient samples.",

year = "2018",

month = may,

day = "1",

doi = "10.1038/s41408-018-0082-7",

language = "אנגלית",

volume = "8",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition

AU - Kahlon, Shira

AU - Shreibman, Dorin

AU - Unger, Tamar

AU - Ben-Yehuda, Dina

AU - Elias, Shlomo

N1 - Funding Information: The study was supported by the Israel Science Foundation (grant 502/15), the Kass Medical Research Award, and the Israeli Society of Hematology and Transfusion Medicine (to S.E.). We thank Dr. Svetelana Krichevsky and Ms. Orly Yehuda Weinstein from Hadassah Medical Center for their help in collecting the human patient samples.

PY - 2018/5/1

Y1 - 2018/5/1

UR - http://www.scopus.com/inward/record.url?scp=85047633162&partnerID=8YFLogxK

U2 - 10.1038/s41408-018-0082-7

DO - 10.1038/s41408-018-0082-7

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 29795444

AN - SCOPUS:85047633162

SN - 2044-5385

VL - 8

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 5

M1 - 48

ER -

The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this